West Paces Advisors Inc. Pfizer Inc Transaction History

West Paces Advisors Inc.

$408 Billion
Q3 2024

A detailed history of West Paces Advisors Inc. transactions in Pfizer Inc stock. As of the latest transaction made, West Paces Advisors Inc. holds 4,531 shares of PFE stock, worth $121,068. This represents 0.03% of its overall portfolio holdings.

Number of Shares

4,531

Previous 4,468 1.41%

Holding current value

$121,068

Previous $125 Million 4.89%

% of portfolio

0.03%

Previous 0.03%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$27.7 - $31.39 $1,745 - $1,977	63 Added 1.41%	4,531 $131 Million
Q2 2024 Jul 16, 2024	SELL	$25.26 - $29.6 $7,805 - $9,146	-309 Reduced 6.47%	4,468 $125 Million
Q1 2024 Apr 15, 2024	SELL	$25.89 - $29.73 $57,294 - $65,792	-2,213 Reduced 31.66%	4,777 $133 Million
Q4 2023 Jan 30, 2024	SELL	$26.13 - $33.94 $34,334 - $44,597	-1,314 Reduced 15.82%	6,990 $201 Million
Q3 2023 Dec 18, 2023	SELL	$32.09 - $37.51 $1,764 - $2,063	-55 Reduced 0.66%	8,304 $275 Million
Q2 2023 Dec 18, 2023	SELL	$36.12 - $41.79 $9,030 - $10,447	-250 Reduced 2.9%	8,359 $307 Million
Q1 2023 Dec 18, 2023	SELL	$39.39 - $51.28 $30,093 - $39,177	-764 Reduced 8.15%	8,609 $351 Million
Q4 2022 Dec 18, 2023	BUY	$41.75 - $54.5 $391,322 - $510,828	9,373 New	9,373 $480 Million
Q2 2022 Dec 18, 2023	BUY	$46.53 - $55.17 $12,981 - $15,392	279 Added 2.9%	9,886 $518 Million
Q1 2022 Dec 18, 2023	BUY	$45.75 - $56.69 $59,612 - $73,867	1,303 Added 15.69%	9,607 $497 Million
Q4 2021 Dec 19, 2023	BUY	$41.32 - $61.25 $14,999 - $22,233	363 Added 4.06%	9,306 $550 Million
Q3 2021 Dec 19, 2023	BUY	$39.25 - $50.42 $79,245 - $101,797	2,019 Added 29.16%	8,943 $385 Million
Q2 2021 Dec 19, 2023	BUY	$35.91 - $40.68 $82,449 - $93,401	2,296 Added 49.61%	6,924 $271 Million
Q1 2021 Dec 19, 2023	BUY	$33.49 - $37.77 $9,008 - $10,160	269 Added 6.17%	4,628 $168 Million
Q4 2020 Dec 19, 2023	SELL	$33.47 - $42.56 $10,241 - $13,023	-306 Reduced 6.56%	4,359 $160 Million
Q3 2020 Dec 19, 2023	SELL	$31.75 - $37.25 $12,700 - $14,900	-400 Reduced 7.9%	4,665 $171 Million
Q2 2020 Dec 19, 2023	SELL	$30.12 - $36.54 $97,558 - $118,353	-3,239 Reduced 39.01%	5,065 $166 Million
Q1 2020 Dec 20, 2023	SELL	$27.03 - $38.62 $265,515 - $379,364	-9,823 Reduced 37.15%	16,617 $542 Million
Q4 2019 Dec 21, 2023	SELL	$32.92 - $37.36 $12,838 - $14,570	-390 Reduced 1.38%	27,833 $1.09 Billion
Q3 2019 Dec 21, 2023	BUY	$32.49 - $42.13 $128,952 - $167,213	3,969 Added 16.36%	28,223 $1.01 Billion
Q2 2019 Dec 21, 2023	SELL	$36.98 - $41.52 $94,520 - $106,125	-2,556 Reduced 9.53%	24,254 $1.05 Billion
Q1 2019 Dec 21, 2023	BUY	$37.5 - $41.2 $19,800 - $21,753	528 Added 2.01%	26,810 $1.14 Billion
Q4 2018 Dec 21, 2023	SELL	$38.47 - $43.86 $15,157 - $17,280	-394 Reduced 1.48%	26,282 $1.15 Billion
Q3 2018 Dec 20, 2023	BUY	$34.47 - $41.81 $625,147 - $758,266	18,136 Added 218.4%	26,440 $1.17 Billion
Q2 2018 Dec 21, 2023	BUY	$32.98 - $35.16 $9,992 - $10,653	303 Added 1.15%	26,676 $968 Million
Q1 2018 Dec 21, 2023	SELL	$31.91 - $37.02 $58,331 - $67,672	-1,828 Reduced 6.48%	26,373 $936 Million
Q4 2017 Dec 21, 2023	SELL	$33.26 - $35.29 $76,697 - $81,378	-2,306 Reduced 7.56%	28,201 $1.02 Billion
Q3 2017 Dec 21, 2023	SELL	$31.0 - $34.15 $5,456 - $6,010	-176 Reduced 0.57%	30,507 $1.09 Billion
Q2 2017 Dec 21, 2023	SELL	N/A	-2,068 Reduced 6.31%	30,683 $1.03 Billion
Q1 2017 Dec 21, 2023	BUY	N/A	2,150 Added 7.03%	32,751 $1.12 Billion
Q4 2016 Dec 21, 2023	BUY	N/A	22,297	30,601 $994 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of West Paces Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on West Paces Advisors Inc. with notifications on news.

Account

West Paces Advisors Inc. Pfizer Inc Transaction History